Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Total Liabilities: 2022-2025

Historic Total Liabilities for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to $52.9 million.

  • Praxis Precision Medicines' Total Liabilities rose 57.44% to $52.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.9 million, marking a year-over-year increase of 57.44%. This contributed to the annual value of $37.7 million for FY2024, which is 106.03% up from last year.
  • Latest data reveals that Praxis Precision Medicines reported Total Liabilities of $52.9 million as of Q3 2025, which was up 8.79% from $48.6 million recorded in Q2 2025.
  • Over the past 5 years, Praxis Precision Medicines' Total Liabilities peaked at $52.9 million during Q3 2025, and registered a low of $18.3 million during Q4 2023.
  • In the last 3 years, Praxis Precision Medicines' Total Liabilities had a median value of $33.6 million in 2024 and averaged $32.3 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first plummeted by 53.16% in 2023, then skyrocketed by 121.32% in 2025.
  • Quarterly analysis of 4 years shows Praxis Precision Medicines' Total Liabilities stood at $39.0 million in 2022, then tumbled by 53.16% to $18.3 million in 2023, then spiked by 106.03% to $37.7 million in 2024, then surged by 57.44% to $52.9 million in 2025.
  • Its Total Liabilities was $52.9 million in Q3 2025, compared to $48.6 million in Q2 2025 and $39.5 million in Q1 2025.